...
首页> 外文期刊>Journal of Molecular and Cellular Cardiology >Isolation and expansion of functionally-competent cardiac progenitor cells directly from heart biopsies.
【24h】

Isolation and expansion of functionally-competent cardiac progenitor cells directly from heart biopsies.

机译:直接从心脏活检组织中分离和扩增具有功能的心脏祖细胞。

获取原文
获取原文并翻译 | 示例

摘要

The adult heart contains reservoirs of progenitor cells that express embryonic and stem cell-related antigens. While these antigenically-purified cells are promising candidates for autologous cell therapy, clinical application is hampered by their limited abundance and tedious isolation methods. Methods that involve an intermediate cardiosphere-forming step have proven successful and are being tested clinically, but it is unclear whether the cardiosphere step is necessary. Accordingly, we investigated the molecular profile and functional benefit of cells that spontaneously emigrate from cardiac tissue in primary culture. Adult Wistar-Kyoto rat hearts were minced, digested and cultured as separate anatomical regions. Loosely-adherent cells that surround the plated tissue were harvested weekly for a total of five harvests. Genetic lineage tracing demonstrated that a small proportion of the direct outgrowth from cardiac samples originates from myocardial cells. This outgrowth contains sub-populations of cells expressing embryonic (SSEA-1) and stem cell-related antigens (c-Kit, abcg2) that varied with time in culture but not with the cardiac chamber of origin. This direct outgrowth, and its expanded progeny, underwent marked in vitro angiogenic/cardiogenic differentiation and cytokine secretion (IGF-1, VGEF). In vivo effects included long-term functional benefits as gauged by MRI following cell injection in a rat model of myocardial infarction. Outgrowth cells afforded equivalent functional benefits to cardiosphere-derived cells, which require more processing steps to manufacture. These results provide the basis for a simplified and efficient process to generate autologous cardiac progenitor cells (and mesenchymal supporting cells) to augment clinically-relevant approaches for myocardial repair.
机译:成年心脏包含表达胚胎和干细胞相关抗原的祖细胞库。虽然这些抗原纯化的细胞有望成为自体细胞治疗的候选药物,但其有限的丰度和繁琐的分离方法阻碍了临床应用。涉及形成中间层的步骤的方法已被证明是成功的,并且正在临床上进行测试,但是尚不清楚是否需要该层的步骤。因此,我们调查了在原代培养中自心脏组织自发迁移的细胞的分子特征和功能优势。将成年Wistar-Kyoto大鼠心脏切碎,消化和培养为单独的解剖区域。每周收获围绕平板组织的松散粘附细胞,共收获五次。遗传谱系追踪表明,心脏样品的直接生长产物中有一小部分来自心肌细胞。这种产物包含表达胚胎(SSEA-1)和干细胞相关抗原(c-Kit,abcg2)的细胞亚群,这些抗原随培养时间而变化,但不随心脏起源腔而变化。这种直接的生长及其扩展的后代经历了显着的体外血管生成/心源性分化和细胞因子分泌(IGF-1,VGEF)。在心肌梗死的大鼠模型中,细胞注射后通过MRI进行的体内功能评估包括长期的功能性益处。向外生长的细胞提供了与心球来源的细胞同等的功能优势,后者需要更多的加工步骤来制造。这些结果为生成自体心脏祖细胞(和间充质支持细胞)以增强临床相关的心肌修复方法提供了简化而有效的过程的基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号